£82.10

Springer - Pharmacological Mechanisms in Alzheimer's Therapeutics

Name: Springer - Pharmacological Mechanisms in Alzheimer's Therapeutics
Brand: Springer
Price: 82.1 GBP
Availability: InStock

Neurology & Clinical Neurophysiology

About as cheap as it gets. The only time it was cheaper was 3 months ago.

£82 today · all-time low £80 (Apr 2026) · usually £84

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 89 days • 89 data points

Historical

Generating forecast...

Price Distribution

Price distribution over 89 days • 5 price levels

Days at Price

Current Price

Price Analysis

Most common price: £84 (41 days, 46.1%)

Price range: £80 - £85

Price levels: 5 different prices over 89 days

Description

Alzheimer's disease remains one of the most significant challenges in modern medicine. As the most common form of dementia in the elderly, the search for treatments that can stop or reverse disease progression is a top priority for the medical community. This professional text from Springer provides a deep look into the current landscape of neurodegenerative research. While no current drug therapy can halt the disease, the identification of promising targets has created significant anticipation for new developments. This book examines these specific targets and the ongoing strategies used to develop effective therapies. It serves as a detailed resource for understanding the pharmacological pathways being investigated to address this devastating condition. By exploring the latest scientific approaches to drug development, this volume provides essential knowledge for those studying or working within the field of neurology and clinical neurophysiology.

Key Features

Investigates promising targets for drug development to address the progression of Alzheimer's disease.

Examines ongoing strategies used to create effective therapies for neurodegenerative conditions.

Provides detailed research on the most common form of dementia found in elderly populations.

Offers insights into the current state of pharmacological research and therapeutic anticipation.

Serves as a technical resource for professionals in neurology and internal medicine.

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 0387715215
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Neurology & Clinical Neurophysiology
Domain: Amazon UK
Release Date: 31 October 2007
Listed Since: 15 May 2007

Barcode

No barcode data available

Springer - Pharmacological Mechanisms in Alzheimer's Therapeutics

About as cheap as it gets. The only time it was cheaper was 3 months ago.

Price History & Forecast

Price Distribution

Price Analysis

Description

Key Features

Product Specifications

Barcode

Similar Products You Might Like

Neuroprotection in Alzheimer's Disease

Alzheimer's Disease and Frontotemporal Dementia: Methods and Protocols: 670 (Methods in Molecular Biology, 670)

Research Progress in Alzheimer's Disease & Dementia: v. 4 (Research Progress in Alzheimer's Disease and Dementia): Volume 4

Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)

Practical Pharmacology for Alzheimer’s Disease

Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)

The End of Alzheimer's: The Brain and Beyond

Practical Pharmacology for Alzheimer’s Disease

Biomarkers for Early Diagnosis of Alzheimer's Disease

Alzheimer’s Disease II: 24 (Topics in Medicinal Chemistry, 24)

Molecular Mechanisms of Dementia (Contemporary Neuroscience)

Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)

Emerging Drugs and Targets for Alzheimer's Disease: Volume 2: Neuronal Plasticity (Drug Discovery Series)